When Sarah, a 34-year-old marketing manager in Ohio, first sought help for depression in early 2022, she expected a blend of medication and regular talk therapy. Her initial psychiatrist offered 50-minute sessions every two weeks, and things seemed manageable. But within six months, her therapist left the practice, and the replacement clinic scheduled only 20-minute slots. “I felt like a checklist item,” she says. “They asked about sleep and appetite, wrote a refill, and sent me out the door.” Sarah’s story is far from unique. Across the United States, antidepressant prescriptions have climbed sharply—according to a 2024 analysis of CDC National Health and Nutrition Examination Survey data, the percentage of adults reporting antidepressant use in the past 30 days rose from about 12% in 2015–2018 to nearly 15% in 2021–2024—while the time patients spend with a therapist or prescriber has contracted to an average of 15 to 20 minutes. This trend forces a difficult question: what does quality mental health care look like when the system prioritizes efficient medication management over the slower, relational work of therapy?

The Widening Gap: More Pills, Less Talk

The divergence between medication and therapy is not subtle. National survey data from the CDC indicate that antidepressant use rose in every adult age group between 2019 and 2024, with the steepest increase among young adults aged 18 to 44. Meanwhile, a 2023 report from the American Psychological Association found that the average psychotherapy session length has declined by roughly 25% over the past decade, with many insurers now reimbursing only 15- to 20-minute medication management visits as the default. The financial incentives are clear: a 15-minute check-in with a psychiatrist or primary care doctor generates a similar reimbursement to a 50-minute therapy session, but allows the clinician to see three or four times as many patients per hour.

Patients often feel the squeeze. In a 2024 survey by Mental Health America, nearly 60% of respondents with depression reported that their most recent mental health visit lasted 20 minutes or less, and over a third said they did not have enough time to discuss side effects or concerns about their medication. The result is a system that can churn out prescriptions efficiently but struggles to provide the listening, skill-building, and relationship that make therapy effective for many people. “We are optimizing for throughput, not outcomes,” says Dr. Lisa Chen, a psychiatrist in Seattle who has written about the trend. Insurance policies reinforce the pattern. Most commercial plans pay for psychotherapy, but often cap the number of sessions or require high copays, while medication management visits are typically covered with lower out-of-pocket costs. Medicare, for instance, reimburses psychiatrists less for a 50-minute psychotherapy session than for a 15-minute medication check, a disparity that has been criticized by professional organizations. A related article on this site, Medicare Pays Psychiatrists Less for Depression Than for Diabetes Monitoring, highlights how payment structures can steer clinicians away from time-intensive talk.

A Patient’s Story: Sarah’s 15-Minute Visit

Sarah’s experience illustrates the human cost of the trend. After her initial therapist left, she transferred to a large community mental health center. Her first appointment was with a psychiatric nurse practitioner who introduced herself, asked a few questions, and prescribed sertraline—all within 20 minutes. “I had read about potential side effects like weight gain and sexual problems, but when I tried to bring them up, she said we could discuss it next time if I had issues,” Sarah recalls. The next visit, three weeks later, lasted 15 minutes. Her dose was increased, and she was told to follow up in a month.

Over the next year, Sarah tried a second clinic with the same pattern: brief visits focused on symptom checklists and prescription adjustments. She never received a referral for cognitive behavioral therapy or any structured talk therapy, despite asking twice. “I felt like a passive recipient of medication, not an active participant in my own recovery,” she says. By late 2023, she was on two antidepressants—sertraline and bupropion—but had not had a therapy session in over eight months. Her depression scores on a standard PHQ-9 questionnaire remained in the moderate range, largely unchanged from when she started.

Sarah’s story is emblematic of a broader pattern. A 2022 study in JAMA Internal Medicine found that among patients newly prescribed antidepressants in primary care, fewer than one in five received any psychotherapy within the first year. The study also noted that patients who did receive concurrent therapy were significantly more likely to achieve remission. For Sarah, the lack of therapy meant she never learned coping strategies for the stress that triggered her depression. “I was just taking pills, waiting for them to fix everything,” she says. “It took me a long time to realize that medication alone wasn’t enough.”

What the Data Shows: National Trends in Prescribing

The numbers behind Sarah’s experience are stark. According to CDC data from the National Health and Nutrition Examination Survey, the percentage of adults reporting antidepressant use in the past 30 days rose from roughly 12% in 2015–2018 to nearly 15% in 2021–2024. The increase was most pronounced among adults aged 18–44, where use jumped from about 8% to 11%. Women are roughly twice as likely as men to take antidepressants, but the rate of increase has been similar across genders.

Primary care doctors now write over 60% of antidepressant prescriptions, a proportion that has grown steadily over the past two decades. While this can improve access for patients who might not otherwise see a specialist, it also means that many prescriptions are written without a comprehensive psychiatric evaluation. A 2023 analysis by the Kaiser Family Foundation found that the average wait time for a new patient appointment with a psychiatrist in the US was roughly 26 days, and in rural areas it could exceed three months. Primary care visits, by contrast, are typically available within a week or two.

The short visit structure itself may drive higher prescribing rates. A 2021 study in the Journal of General Internal Medicine examined over 10,000 primary care visits for depression and found that visits lasting 15 minutes or less were associated with a 30% higher likelihood of receiving a new antidepressant prescription compared with visits lasting 30 minutes or longer. The authors suggested that when time is limited, clinicians may default to medication as the most efficient intervention, even when therapy might be more appropriate. The pattern echoes findings in other countries; for instance, a related article on this site, Borderline Personality Disorder Patients in Rural Clinics Receive Diazepine Sedatives Instead of Psychotherapy, shows how time constraints can lead to reliance on medications in place of evidence-based talk therapies.

The Economics of 15-Minute Therapy

The shift toward shorter sessions is fundamentally an economic story. Insurance reimbursement rates for psychotherapy have not kept pace with inflation, and many insurers have tightened their coverage of therapy in recent years. A 2024 analysis by the RAND Corporation found that the average allowed amount for a 50-minute psychotherapy session under commercial insurance was roughly $90 in 2023, only marginally higher than a decade earlier when adjusted for inflation. By contrast, a 15-minute medication management visit reimburses around $60 to $80, meaning a clinician can earn $240 to $320 per hour by seeing four patients in brief slots, compared with $90 for a single therapy hour.

Clinics, especially those serving publicly insured or low-income patients, have responded by maximizing volume. Community mental health centers, which often operate on thin margins, have increasingly moved to 15- or 20-minute medication checks as their default appointment type. Telehealth, which expanded rapidly during the pandemic, has also played a role. While telehealth has improved access for many—especially in rural areas—it has also compressed session length. A 2023 study in Health Affairs found that tele-mental health visits averaged 22 minutes, compared with 38 minutes for in-person visits, partly because clinicians schedule shorter slots to accommodate back-to-back virtual appointments.

For patients, the cost of longer therapy is often prohibitive. Out-of-network therapy sessions can cost $150 to $250 per hour, and even in-network plans may require a $40 to $60 copay per session. For someone needing weekly therapy, that can add up to hundreds of dollars a month. “I looked into seeing a private therapist, but it was $180 a session and my insurance only covered six visits a year,” Sarah says. “I couldn’t afford that.” The result is a bifurcated system where those with means can access longer, more comprehensive care, while others are funneled into the medication-only, short-visit track.

Evidence on What Gets Lost in Short Sessions

Research suggests that the compressed visit format carries real clinical costs. A 2022 meta-analysis in the Journal of Consulting and Clinical Psychology reviewed 42 studies on psychotherapy session length and found that, for moderate to severe depression, sessions lasting 45 to 60 minutes produced significantly better outcomes than sessions of 30 minutes or less. The effect was especially pronounced for treatments that require active skill-building, such as cognitive behavioral therapy or interpersonal therapy. Short sessions, the authors noted, tend to focus on symptom monitoring and medication management, leaving little room for the therapeutic work that helps patients develop lasting coping mechanisms.

Another concern is the therapeutic alliance—the bond between patient and clinician that predicts treatment success across many modalities. A 2021 study in Psychotherapy Research found that alliance ratings were significantly lower in visits lasting under 20 minutes compared with longer sessions, and that lower alliance scores predicted higher dropout rates. Patients in the short-visit group were also less likely to report feeling understood or to disclose sensitive information, such as suicidal thoughts or medication side effects. “You can’t build a trusting relationship in 15 minutes,” says Dr. Chen. “It’s possible to do a lot of damage by rushing—patients may feel dismissed, and they may stop coming back.”

Complex cases are particularly vulnerable. Patients with comorbid conditions—such as depression plus anxiety, substance use, or trauma—often need more time for assessment and coordination. A 2023 report from the National Council for Mental Wellbeing found that nearly 40% of adults with depression also meet criteria for an anxiety disorder, yet integrated treatment is rare in brief visits. The report noted that short medication checks often miss these comorbidities, leading to incomplete treatment plans. Similarly, patients on multiple medications may require careful monitoring for interactions and side effects, which is difficult to accomplish in a 15-minute window.

Where the System Could Go Next

Despite the grim picture, there are signs of movement toward better models. One promising approach is collaborative care, a team-based model in which a primary care provider works with a care manager and a consulting psychiatrist to deliver both medication and brief therapy. A 2024 Cochrane review found that collaborative care improved depression outcomes compared with usual primary care, with effect sizes similar to those of full-length psychotherapy. The model has been adopted by several large health systems, including Kaiser Permanente and the Veterans Health Administration, and is being tested in community health centers across the country.

Policy changes could also help. A handful of states have passed mental health parity laws that require insurers to cover therapy at the same level as medical visits, though enforcement remains uneven. Federal legislation, such as the Mental Health Access Improvement Act, has expanded coverage for marriage and family therapists and mental health counselors under Medicare, but psychotherapy reimbursement rates have not been updated. Advocacy groups like the American Psychological Association are pushing for minimum session duration standards in public insurance programs, arguing that 15-minute visits should not be the default for patients with moderate to severe depression.

Digital tools offer another lever, though they are not a panacea. Smartphone apps for mood tracking, cognitive behavioral therapy exercises, and peer support can supplement brief visits, giving patients skills and data to bring to their clinician. A 2023 study in JAMA Network Open found that patients who used a digital CBT app alongside medication management had better outcomes than those who received medication alone. But digital tools cannot replace the human connection that many patients need. “The apps are useful, but they don’t listen to you,” Sarah says. “I need someone who can hear what I’m not saying.”

Training more non-physician therapists could also ease the shortage. Over the past decade, the number of licensed professional counselors and marriage and family therapists has grown faster than the number of psychiatrists, but they are often excluded from insurance networks or limited in what they can bill. Expanding their role in integrated care settings—where they can provide longer therapy sessions—could help close the gap. Some states, such as California and New York, have invested in loan repayment programs for mental health professionals who work in underserved areas, but the impact on session length is still unclear.

Alternatives to the Brief Visit Model

Beyond collaborative care, other models are emerging that challenge the 15-minute default. Stepped care, for instance, begins with low-intensity interventions—such as guided self-help or group therapy—and reserves longer individual sessions for those who do not improve. A 2023 trial in the UK found that stepped care for depression reduced the need for intensive therapy without compromising outcomes, though it required careful monitoring to ensure patients were stepped up when needed. In the US, some health plans have experimented with “measurement-based care,” where patients complete brief symptom questionnaires before each visit, allowing clinicians to focus on key issues even in short appointments. While this can make brief visits more efficient, it does not address the loss of therapeutic relationship that comes with rushed encounters.

Another approach is to separate the roles of prescriber and therapist more explicitly. In some integrated clinics, a psychiatrist or nurse practitioner handles medication management in short visits, while a separate therapist provides longer talk therapy sessions. This division of labor can work well when the two clinicians communicate regularly, but in practice, coordination is often poor. A 2022 study in Psychiatric Services found that in clinics where prescribers and therapists were in the same building, only about half had regular case conferences. Without communication, patients can receive conflicting advice or feel caught between two providers.

Patient advocacy groups have also proposed regulatory changes. For example, some have called for insurers to require that initial psychiatric evaluations be at least 45 minutes long, with shorter follow-ups only for stable patients. The American Psychiatric Association has endorsed similar guidelines, but they are not enforceable. In the absence of regulation, patients and clinicians must navigate a system where the default is increasingly brief.

Broader Implications for Mental Health Care

The trend toward shorter sessions and more prescriptions reflects deeper shifts in how mental health care is valued. When a 15-minute medication check reimburses nearly as much as a 50-minute therapy session, the message is clear: the system rewards efficiency over depth. This has consequences not only for individual patients but for the profession itself. Psychiatrists, who once trained primarily as psychotherapists, now spend most of their time on medication management. A 2023 survey by the American Association of Medical Colleges found that fewer than 20% of psychiatrists reported providing psychotherapy to a majority of their patients, down from over 50% in the 1990s. For many, the financial pressures of running a practice make longer sessions unsustainable.

The shift also affects training. Psychiatry residents today receive less supervision in psychotherapy than previous generations, partly because their supervisors are also seeing patients in short visits. A 2021 study in Academic Psychiatry found that residency programs reported a decline in the number of hours devoted to psychotherapy training, with many programs now emphasizing psychopharmacology and brief interventions. This creates a cycle: clinicians trained in brief visits are more likely to use them, and the next generation learns the same pattern.

For patients, the consequences are measured in missed opportunities. Depression is a chronic condition for many, and effective treatment often requires a combination of medication, skill-building, and support over months or years. Brief visits can manage symptoms in the short term, but they may not address the underlying factors that keep people unwell. Sarah’s experience is a case in point: after two years of medication-only care, her depression was only partially improved. It was only when she found a therapist through a low-cost training clinic that she began to make lasting progress. “The therapy helped me understand why I got depressed in the first place,” she says. “The pills helped with the symptoms, but they didn’t change the patterns.”

This article is for informational purposes only and does not constitute personalized medical advice. If you are experiencing a mental health crisis, please contact your healthcare provider or call 988 (the Suicide and Crisis Lifeline).